We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

1 hedge funds and large institutions have $5 invested in Histogen Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% less funds holding

Funds holding: 91 (-8)

100% less capital invested

Capital invested by funds: $9.53K → $5 (-$9.52K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 8

Holders
1
Holders Change
-8
Holders Change %
-88.89%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
8
Calls
Puts
Net Calls
Net Calls Change

HSTO Hedge Fund Activity: Q4 2023 in Review

1 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q4 2023, worth a combined $5 — down 100% from $9.53K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of HSTO and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Synovus Financial, exiting entirely with an estimated $5.17K sold.

  • 1 institutional investor held Histogen Inc. Common Stock (HSTO) as of Q4 2023, down from 9 in Q3 2023.
  • Funds reported $5 of Histogen Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Histogen Inc. Common Stock positions in Q4 2023 and 8 closed out, a net change of -8 holders.
  • The largest Histogen Inc. Common Stock seller in Q4 2023 was Synovus Financial, an estimated $5.17K sold.

Based on aggregated 13F filings for Q4 2023.